Research powered investment banking
Home
Research
Companies
Themes
Top Picks
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
Posts
Investor Scoring
sign in
Member sign in
Join redeye
Home
research
Companies
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
community
Posts
Investor Scoring
The latest from Redeye about Scandinavian Life Science and Technology companies
Orexo
Orexo: Zubsolv – prescription data update
Hexatronic Group
Intervju med vd Henrik Larsson Lyon (video)
Aspire Global
Q2 preview, expecting strong Y/Y growth
Westpay
First comment Q2, mostly in-line
Fingerprint Cards
Q2'19: Weak gross margins but cards are progressing well
Christian Berner Tech Trade
Q2’19: Preview
Impact Coatings
Q2’19: First comment
XMReality
Q2’19: Lower than expected sales
Hexatronic Group
Q2’19: First comment
Karolinska Development
Subscription period extended again
Invisio Communications
Stark rapport - men högre OPEX än väntat
Invisio Communications
Vinner upphandling rörande USAs marinkår - Redeyes kommentar
Opus Group
EBITA-marginal på ny toppnivå
Neonode Inc
Touching the bottom?
Events
20
Aug
Aspire Global: Live Quarterly Report Presentation and Q&A (English)
20
Aug
Immunicum: Quarterly Report Presentation & Business Strategy Review (English)
21
Aug
IMINT: Live Quarterly Presentation and Q&A (Swedish)
22
Aug
Speqta: Live Quarterly Presentation (Swedish)
28
Aug
Cancer Imaging Lunch
29
Aug
Investor Lunch
Announcements
New accounting principle to affect upcoming interim reports
Redeye söker Projektledare inom Corporate Finance
Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten